Calidi Biotherapeutics, Inc. Capital Expenditures Incurred but Not yet Paid
Calidi Biotherapeutics, Inc. (CLDI) reported Capital Expenditures Incurred but Not yet Paid of $26.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2024-08-13
- Calidi Biotherapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2023-06-30 was -$223.00K.
- Calidi Biotherapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2023-03-31 was $249.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month |
|---|---|---|
| 2023-06-30 | -$223.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $26.00K 10-Q · filed 2024-08-13 |
| 2023-03-31 | $249.00K 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |